Homeclinical_biochemistryexamination_procedures
                    Uric Acid Examination Procedure

1.Purpose of examination: Uric acid estimation from serum or plasma by Uricase Method.

2.Responsibility and Authority:

3.Sample Details:

  1. Type of Sample: Serum, Plasma
  2. Type of container and additives: Plain without any additives
  3. Patient Preparation: As per Primary Sample Collection Manual sample_collection_manual
  4. Stability: At Room temperature 18°–28°C (64°–82°F) stability ≤ 24 hours
  5. Handling and transport: As per Primary Sample collection manual
  6. Storage: 24 hours at 2-8° C

4.Required Equipment: Centrifuge, Auto-Pipette, Disposable Tips, Disposable sample cups, FullyAuto Chemistry Analyzer

5.Required reagents: R1 TODB (0.847 g/L). R2 4-aminoantipyrine (0.285 g/L), TODB (0.847 g/L). peroxidase (POD) (4.000 KU/L), uricase (2.000 KU/L).

6.Reagent Handling

7.Reagent Storage and stability

8.Calibration Procedure: Consolidated Chemistry Calibrator Frequency:

  1. Reagent lot change
  2. QC out of range
  3. After service or maintenance
  4. Replacement in any parts of Instrument

Procedure:

  1. Start the equipment.WDI abbotte fully.docx
  2. Calibrators are ready to use.
  3. Put calibrator 15-20 minutes at room temperature
  4. Prior to use, mix the contents by inverting the vial. Do not shake the vial to prevent foam formation.
  5. Take a 150 µl calibrator solution inseparate aliquot.
  6. Go to the calibration and give the calibration order.
  7. Verify calibration with at least two levels of controls
  8. If control results fall outside acceptable ranges,root cause analysis or recalibration may be necessary.

9.Quality control Procedure:

10.Procedure for Reconstitution of IQC

  1. Reconstitution of QC material with 5 ml Distilled water by using calibrated fixed volume pipette.
  2. Leave to stand for 30 min in the dark place.
  3. Swirl gently several times during the reconstitution period to ensure that the contents are completely dissolved.
  4. Prior to use, mix the contents by inverting the vial. Do not shake the vial as the information of foam should be avoided. Ensure that no lyophilized material remains un-reconstituted.
  5. Prepare aliquots of 150 µl from the reconstituted QC material.
  6. Store these aliquots at -15° C to -20° C.
  7. Prior to use, make sure that aliquots should be at room temperature for at least 15 min.

Procedure to run IQC

  1. Press Control order
  2. Select Assay /Panel, to be run.
  3. Select the control/s and its level/s
  4. Give Carrier Number and Position number
  5. Press F3 / Add order
  6. Put respected carrier in RSH rack
  7. Check IQC results, in case outliers call residents.

11.Principle of the procedure used for examinations:

12.Sample Preparation:

Take 150-200µl of the sample from Primary tube to the secondary aliquot. Write the sample ID on the aliquot.

Procedure to run Patient sample

13.Performance Characteristics: Linearity: of 0.3 to 37.7 mg/dL

Automated Dilution Protocol: When using the Automated Dilution Protocol, the system performs a dilution of the specimen and automatically corrects the concentration by multiplying the result by the appropriate dilution factor. Manual Dilution Procedure: Dilute the specimen with saline (0.85% to 0.90% NaCl). Enter the dilution factor in the Patient or Control order screen

Normal and critical ranges:

Uric acid

Male3.5-7.2mg/dL
Female2.6-6.0mg/dL

14.Laboratory Clinical interpretation: The Uric Acid 2 assay is to be used as an aid in the diagnosis and treatment of numerous renal and metabolic disorders, including renal failure, gout, leukemia, psoriasis, starvation or other wasting conditions, and of patients receiving cytotoxic drugs. Decreased levels are present in patients with Wilson’s disease.

15.Interference and cross reaction: The Following analytes were tested up to the two levels indicated at Uric Acid concentrations of (approximately 4 mg/dL and 7 mg/dL). and found not to interfere: Interfering Substance

Turn around time (TAT):

16.Recording of observation:

17.Storage & Disposal of waste: Follow storage & discard procedure

18.Environmental & Safety control: Reagent R1 contains methylchloroisothiazolone and boric acid that causes allergic skin reaction,and damafe fertility or unborn child.

19.Precautions:

Response

IF SWALLOWED: Rinse mouth. Do NOT induce vomiting IF IN EYES: * Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do.

IF ON SKIN (or hair):

For Reagent R2:

20.References:

  1. World health organization. Biosafety manual,3rd edition.
  2. Burtis CA,Ashwood ER,editors,Tietz Textbook of clinical chemistry
  3. Kaplan LA,Pesce AJ editors. Clinical Chemistry Theory, Analysis, and Correlation, 3rd ed.
Printed copy of this document is considered uncontrolled. It should be compared with controlled electronic copy before use
Name of Laboratory : Laboratory Services Sir T. Hospital (LSSTH),Bhavnagar
Document No.1Document Name: Uric Acid Examination ProcedureUnique ID:LSSTH /BIOCHEM/ SOP-5
Issue No. : 01Issue Date :30/04/2024Page No.
Amend No. Amend Date Prepared by: Section InchargeApproved & Issued by: HOD,Biochemistry